The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 08, 2022
Filed:
Jun. 09, 2020
Applicant:
Filtricine, Inc., Mountain View, CA (US);
Inventors:
Assignee:
Filtricine, Inc., Mountain View, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/198 (2006.01); A61K 31/7004 (2006.01); A61K 31/375 (2006.01); A61K 33/26 (2006.01); A61K 33/34 (2006.01); A61K 33/24 (2019.01); A61K 33/16 (2006.01); A61K 33/18 (2006.01); A61K 33/32 (2006.01); A61K 33/04 (2006.01); A61K 33/30 (2006.01); A61K 31/714 (2006.01); A61K 31/07 (2006.01); A61K 31/675 (2006.01); A61K 31/355 (2006.01); A61K 31/519 (2006.01); A61K 31/593 (2006.01); A61K 31/51 (2006.01); A61K 31/525 (2006.01); A61K 31/455 (2006.01); A61K 31/4188 (2006.01); A61K 31/14 (2006.01);
U.S. Cl.
CPC ...
A61K 31/198 (2013.01); A61K 31/07 (2013.01); A61K 31/14 (2013.01); A61K 31/355 (2013.01); A61K 31/375 (2013.01); A61K 31/4188 (2013.01); A61K 31/455 (2013.01); A61K 31/51 (2013.01); A61K 31/519 (2013.01); A61K 31/525 (2013.01); A61K 31/593 (2013.01); A61K 31/675 (2013.01); A61K 31/7004 (2013.01); A61K 31/714 (2013.01); A61K 33/04 (2013.01); A61K 33/16 (2013.01); A61K 33/18 (2013.01); A61K 33/24 (2013.01); A61K 33/26 (2013.01); A61K 33/30 (2013.01); A61K 33/32 (2013.01); A61K 33/34 (2013.01);
Abstract
The present disclosure provides compositions and methods for treating cancer with nutritionally modified diets and/or dialysis treatment, such as through amino acid depletion of one or more nonessential amino acids. In some aspects, the present disclosure provides compositions and methods for treating obesity with such modified diets and/or dialysis treatment. Furthermore, in some aspects, the present disclosure provides compositions and methods for treating renal disease with such modified diets and/or dialysis treatment.